help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenfeld, M. E.
Right arrow Articles by Fausto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenfeld, M. E.
Right arrow Articles by Fausto, N.
(American Journal of Pathology. 2000;156:997-1007.)
© 2000 American Society for Investigative Pathology


Regular Articles

Prevention of Hepatic Apoptosis and Embryonic Lethality in RelA/TNFR-1 Double Knockout Mice

Maryland E. Rosenfeld*, Lisa Prichard*, Nobuyoshi Shiojiri{dagger} and Nelson Fausto*

From the Department of Pathology,*
University of Washington, Seattle, Washington; and the Department of Biology,{dagger}
Shizuoka University, Shizuoka, Japan

Mice deficient in the nuclear factor {kappa}B (NF-{kappa}B)-transactivating gene RelA (p65) die at embryonic days 14–15 with massive liver apoptosis. In the adult liver, activation of the NF-{kappa}B heterodimer RelA/p50 can cause hepatocyte proliferation, apoptosis, or the induction of acute-phase response genes. We examined, during wild-type fetal liver development, the expression of the Rel family member proteins, as well as other proteins known to be important for NF-{kappa}B activation. We found these proteins and active NF-{kappa}B complexes in the developing liver from at least 2 days before the onset of lethality observed in RelA knockouts. This suggests that the timing of NF-{kappa}B activation is not related to the timing of lethality. We therefore hypothesized that, in the absence of RelA, embryos were sensitized to tumor necrosis factor (TNF) receptor 1 (TNFR-1)-mediated apoptosis. Thus, we generated mice that were deficient in both RelA and TNFR-1 to determine whether apoptotic signaling through TNFR-1 was responsible for the lethal phenotype. RelA/TNFR-1 double knockout mice survived embryonic development and were born with normal livers without evidence of increased hepatocyte apoptosis. These animals became runted shortly after birth and survived an average of 10 days, dying from acute hepatitis with an extensive hepatic infiltration of immature neutrophils. We conclude that neither RelA nor TNFR-1 is required for liver development and that RelA protects the embryonic liver from TNFR-1-mediated apoptotic signals. However, the absence of both TNFR-1 signaling and RelA activity in newborn mice makes these animals susceptible to endogenous hepatic infection.





This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. Wullaert, G. van Loo, K. Heyninck, and R. Beyaert
Hepatic Tumor Necrosis Factor Signaling and Nuclear Factor-{kappa}B: Effects on Liver Homeostasis and Beyond
Endocr. Rev., June 1, 2007; 28(4): 365 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Quinton, M. R. Jones, B. T. Simms, M. S. Kogan, B. E. Robson, S. J. Skerrett, and J. P. Mizgerd
Functions and Regulation of NF-{kappa}B RelA during Pneumococcal Pneumonia
J. Immunol., February 1, 2007; 178(3): 1896 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. C. Sadler, K. N. Krahn, N. A. Gaur, and C. Ukomadu
Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1
PNAS, January 30, 2007; 104(5): 1570 - 1575.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
R. Seymour, J. P. Sundberg, and H. HogenEsch
Abnormal lymphoid organ development in immunodeficient mutant mice.
Vet. Pathol., July 1, 2006; 43(4): 401 - 423.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Nagashima, V. G. Sasseville, D. Wen, A. Bielecki, H. Yang, C. Simpson, E. Grant, M. Hepperle, G. Harriman, B. Jaffee, et al.
Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta
Blood, June 1, 2006; 107(11): 4266 - 4273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-L. Cho, J.-W. Kang, Y.-M. Moon, H.-J. Nam, J.-Y. Jhun, S.-B. Heo, H.-T. Jin, S.-Y. Min, J.-H. Ju, K.-S. Park, et al.
STAT3 and NF-{kappa}B Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice
J. Immunol., May 1, 2006; 176(9): 5652 - 5661.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Haouzi, S. Baghdiguian, G. Granier, P. Travo, P. Mangeat, and U. Hibner
Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling
J. Cell Sci., June 15, 2005; 118(12): 2763 - 2773.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. S. Pryhuber, H. L. Huyck, J. M. Roper, J. Cornejo, M. A. O'Reilly, R. H. Pierce, and E. N. Tsitsikov
Acute Tumor Necrosis Factor-{alpha}-Induced Liver Injury in the Absence of Tumor Necrosis Factor Receptor-Associated Factor 1 Gene Expression
Am. J. Pathol., June 1, 2005; 166(6): 1637 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Liu, C. Li, Y. Chen, C. Burnett, X. Y. Liu, S. Downs, R. D. Collins, and J. Hawiger
Nuclear Import of Proinflammatory Transcription Factors Is Required for Massive Liver Apoptosis Induced by Bacterial Lipopolysaccharide
J. Biol. Chem., November 12, 2004; 279(46): 48434 - 48442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. G. Cavin, M. Venkatraman, V. M. Factor, S. Kaur, I. Schroeder, F. Mercurio, A. A. Beg, S. S. Thorgeirsson, and M. Arsura
Regulation of {alpha}-Fetoprotein by Nuclear Factor-{kappa}B Protects Hepatocytes from Tumor Necrosis Factor-{alpha} Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis
Cancer Res., October 1, 2004; 64(19): 7030 - 7038.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Gugasyan, A. Voss, G. Varigos, T. Thomas, R. J. Grumont, P. Kaur, G. Grigoriadis, and S. Gerondakis
The Transcription Factors c-rel and RelA Control Epidermal Development and Homeostasis in Embryonic and Adult Skin via Distinct Mechanisms
Mol. Cell. Biol., July 1, 2004; 24(13): 5733 - 5745.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S Finotto, J Siebler, M Hausding, M Schipp, S Wirtz, S Klein, M Protschka, A Doganci, H A Lehr, C Trautwein, et al.
Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo
Gut, March 1, 2004; 53(3): 392 - 400.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Y. Zhang, C. L. Green, S. Tao, and P. A. Khavari
NF-{kappa}B RelA opposes epidermal proliferation driven by TNFR1 and JNK
Genes & Dev., January 1, 2004; 18(1): 17 - 22.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
C. J. Zeiss
The Apoptosis-Necrosis Continuum: Insights from Genetically Altered Mice
Vet. Pathol., September 1, 2003; 40(5): 481 - 495.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Chen, M. Kwong, R. Lu, D. Ginzinger, C. Lee, L. Leung, and J. Y. Chan
Nrf1 Is Critical for Redox Balance and Survival of Liver Cells during Development
Mol. Cell. Biol., July 1, 2003; 23(13): 4673 - 4686.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Cusson, S. Oikemus, E. D. Kilpatrick, L. Cunningham, and M. Kelliher
The Death Domain Kinase RIP Protects Thymocytes from Tumor Necrosis Factor Receptor Type 2-induced Cell Death
J. Exp. Med., July 1, 2002; 196(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Chi, F. Diaz-Griffero, C. Wang, J. A. T. Young, and J. Brojatsch
An NF-{kappa}B-Dependent Survival Pathway Protects against Cell Death Induced by TVB Receptors for Avian Leukosis Viruses
J. Virol., May 3, 2002; 76(11): 5581 - 5587.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. G. Kupfner, J. J. Arcaroli, H.-K. Yum, S. G. Nadler, K.-Y. Yang, and E. Abraham
Role of NF-{kappa}B in Endotoxemia-Induced Alterations of Lung Neutrophil Apoptosis
J. Immunol., December 15, 2001; 167(12): 7044 - 7051.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Hayashi and D. L. Faustman
Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis
J Appl Physiol, December 1, 2001; 91(6): 2804 - 2815.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. Silverman and T. Maniatis
NF-{kappa}B signaling pathways in mammalian and insect innate immunity
Genes & Dev., September 15, 2001; 15(18): 2321 - 2342.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Chen, V. Castranova, and X. Shi
New Insights into the Role of Nuclear Factor-{kappa}B in Cell Growth Regulation
Am. J. Pathol., August 1, 2001; 159(2): 387 - 397.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Alcamo, J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes, and D. Baltimore
Targeted Mutation of TNF Receptor I Rescues the RelA-Deficient Mouse and Reveals a Critical Role for NF-{kappa}B in Leukocyte Recruitment
J. Immunol., August 1, 2001; 167(3): 1592 - 1600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. H. Pierce, J. S. Campbell, A. B. Stephenson, C. C. Franklin, M. Chaisson, M. Poot, T. J. Kavanagh, P. S. Rabinovitch, and N. Fausto
Disruption of Redox Homeostasis in Tumor Necrosis Factor-Induced Apoptosis in a Murine Hepatocyte Cell Line
Am. J. Pathol., July 1, 2000; 157(1): 221 - 236.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. S. Sylla, K. Murphy, E. Cahir-McFarland, W. S. Lane, G. Mosialos, and E. Kieff
The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B
PNAS, June 13, 2000; (2000) 130193097.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. S. Sylla, K. Murphy, E. Cahir-McFarland, W. S. Lane, G. Mosialos, and E. Kieff
The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B
PNAS, June 20, 2000; 97(13): 7470 - 7475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.